FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and aims at treating schizophrenia. A method of treating, preventing, delaying the progression or onset and/or development of schizophrenia involves administering an effective amount of a combined therapy containing dimebon and risperidone into the patient. A pharmaceutically acceptable composition for treating, preventing, delaying the progression or onset and/or development of schizophrenia contains dimebon and risperidone. A kit for treating, preventing, delaying the progression or onset and/or development of schizophrenia contains dimebon and risperidone, and a package leaflet.
EFFECT: using the declared group of inventions enables increasing the clinical effect of treating schizophrenia.
7 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508096C2 |
| AGENT FOR TREATMENT OF SCHIZOPHRENIA ON BASIS OF HYDROGENATED PYDIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND METHOD OF ITS APPLICATION | 2006 |
|
RU2338537C2 |
| AGENT FOR TREATMENT OF ACUTE AND CHRONIC DISTURBANCES OF CEREBRAL CIRCULATION, INCLUDING STROKE ON BASIS OF HYDROGENATED PYRIDO (4,3-b)INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND METHOD OF ITS APPLICATION | 2006 |
|
RU2340342C2 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| GEROPROTECTING AGENT BASED ON HYDROGENATED PYRIDO[4,3-b]INDOLES (VARIANTS), PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD FOR ITS USING | 2003 |
|
RU2283108C2 |
| AGENT POSSESSING ANXIOLYTHIC ACTION, ON BASIS OF HYDROGENATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND WAY OF ITS APPLICATION | 2007 |
|
RU2338533C1 |
| REMEDY FOR IMPROVEMENT OF COGNITIVE FUNCTIONS AND MEMORY BASED ON HYDRATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL REMEDY BASED THEREON AND METHOD OF APPLICATION THEREOF | 2006 |
|
RU2334514C1 |
| AGENT FOR NEUTRALISING TOXIC ACTION OF TUMOUR NECROSIS FACTOR ON BASIS OF HYDRATED PYRIDO(4,3-b)INDOLES, PHARMACOLOGICAL AGENT ON ITS BASIS AND METHOD OF TREATING AUTOIMMUNE DISEASE ON BASIS OF NEUTRALISING TOXIC ACTION OF TUMOUR NECROSIS FACTOR | 2012 |
|
RU2477131C1 |
| NEW APPROACH TO TREATMENT OF ALZHEIMER'S DISEASE | 1995 |
|
RU2106864C1 |
| METHOD FOR PRODUCTION OF CLOZAPINE PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS AND PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2441651C1 |
